Comparison of the use of screening tools for evaluating cognitive impairment in patients with Parkinson's disease
Carlos Henrique Ferreira Camargo1; Eduardo de Souza Tolentino2; Augusto Bronzini2; Marcelo de Araújo Ladeira2; Ronilson Lima2; Gustavo Leopold Schultz-Pereira3; Marcelo Rezende Young-Blood4
keywords: Parkinson's disease, dementia, cognition.
BACKGROUND: Screening tests have been used for cognitive deficits in Parkinson's disease (PD).
OBJECTIVE: This study compared the Montreal Cognitive Assessment (MoCA) test, the Mini-Mental State Examination (MMSE) and the clock drawing test for this purpose.
METHODS: A total of 50 patients with PD were selected, 41 (82%) were diagnosed with dementia by the criteria of the Movement Disorder Society. The test Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog) was used as the gold standard in comparison with the screening tests.
RESULTS: The MoCA test (AUC=0.906) had a sensitivity of 87.80% and specificity of 88.89%. When the MMSE was associated with the clock drawing test (AUC=0.936), it had a specificity of 66.67% and sensitivity of up to 97.56%.
CONCLUSION: The study suggests that the MoCA test can be a good screening test in PD. However, MMSE associated with the clock drawing test may be more effective than the MoCA test.